De(5-carboxamide)oxcarbazepine
Code | Size | Price |
---|
TAR-T20942-5mg | 5mg | £409.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T20942-10mg | 10mg | £670.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T20942-25mg | 25mg | £1,247.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
De(5-carboxamide)oxcarbazepine is used for organic synthesis.
CAS:
21737-58-6
Formula:
C14H11NO
Molecular Weight:
209.248
Purity:
0.98
SMILES:
O=C1Cc2ccccc2Nc2ccccc12
References
1. Bialer M, Soares-da-Silva P. Pharmacokinetics and drug interactions of eslicarbazepine acetate. Epilepsia. 2012 Jun;53(6):935-46. doi: 10.1111/j.1528-1167.2012.03519.x. Epub 2012 May 21. Review. PubMed PMID: 22612290.
2. Fortuna A, Alves G, Falc?o A, Soares-da-Silva P. Evaluation of the permeability and P-glycoprotein efflux of carbamazepine and several derivatives across mouse small intestine by the Ussing chamber technique. Epilepsia. 2012 Mar;53(3):529-38. doi: 10.1111/j.1528-1167.2012.03409.x. PubMed PMID: 22372629.
3. Di Resta C, Ambrosi P, Curia G, Becchetti A. Effect of carbamazepine and oxcarbazepine on wild-type and mutant neuronal nicotinic acetylcholine receptors linked to nocturnal frontal lobe epilepsy. Eur J Pharmacol. 2010 Sep 15;643(1):13-20. doi: 10.1016/j.ejphar.2010.05.063. Epub 2010 Jun 16. PubMed PMID: 20561518.
4. Ayala-Guerrero F, Mexicano G, Campos-Sep?lveda E, Romero RM, Reynoso-Robles R, Gonz?lez-Maciel A. Effect of oxcarbazepine pretreatment on convulsive activity and brain damage induced by kainic acid administration in rats. Comp Biochem Physiol A Mol Integr Physiol. 2008 Nov;151(3):471-6. Epub 2007 Jun 23. PubMed PMID: 17669675.